Rachel Lenington - Jun 14, 2021 Form 3 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Chief Technology Officer
Signature
/s/ Glenna Mileson, Attorney in Fact for Rachel Lenington
Stock symbol
ATHA
Transactions as of
Jun 14, 2021
Transactions value $
$0
Form type
3
Date filed
6/14/2021, 04:58 PM
Next filing
Nov 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATHA No securities are beneficially owned. 0 Jun 14, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATHA No securities are beneficially owned. Jun 14, 2021 Not Applicable 0 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.